Fei Hu Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fei Hu Chen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Xin Hua Liu
Anhui Medical University
2 shared publications Hai Pin Zhou
School of Material Science Chemical Engineering, ChuZhou University, ChuZhou 239000, PR China
1 shared publicationHua Zhou
1 shared publicationJiang-Qun Cheng
1 shared publicationLiu Zeng Chen
School of Pharmacy, Anhui Medical University, Hefei 230032, PR China
1 shared publicationZhi Sen Wang
School of Pharmacy, Anhui Medical University, Hefei 230032, PR China
1 shared publication
Latest Publications
- 1 April 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (8) , 1803-1807
Diarylpentadienone derivatives (curcumin analogues): Synthesis and anti-inflammatory activity
- 1 April 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (8) , 1803-1807
Diarylpentadienone derivatives (curcumin analogues): Synthesis and anti-inflammatory activity
- 21 October 2016
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 16 (30) , 3582-3589
Oxazole: A Promising Building Block for the Development of Potent Antitumor Agents
Oxazole derivatives are found to have a variety of biological activities. A large number of studies have revealed their outstanding anticancer activities. Here we review four different types of oxazole derivatives with anticancer potential reported over the last ten years. We focus our discussion on their activity, selectivity in different cancer cell lines, mechanisms of action, and their structural evolution.
- 21 October 2016
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 16 (30) , 3582-3589
Oxazole: A Promising Building Block for the Development of Potent Antitumor Agents
Oxazole derivatives are found to have a variety of biological activities. A large number of studies have revealed their outstanding anticancer activities. Here we review four different types of oxazole derivatives with anticancer potential reported over the last ten years. We focus our discussion on their activity, selectivity in different cancer cell lines, mechanisms of action, and their structural evolution.